loading
Schlusskurs vom Vortag:
$421.60
Offen:
$423.74
24-Stunden-Volumen:
137.15K
Relative Volume:
0.39
Marktkapitalisierung:
$9.52B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-518.67M
KGV:
-17.06
EPS:
-25.12
Netto-Cashflow:
$-438.32M
1W Leistung:
+1.12%
1M Leistung:
-6.55%
6M Leistung:
+28.36%
1J Leistung:
+98.50%
1-Tages-Spanne:
Value
$420.50
$434.98
1-Wochen-Bereich:
Value
$393.61
$436.84
52-Wochen-Spanne:
Value
$238.04
$463.62

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

Name
Firmenname
Madrigal Pharmaceuticals Inc
Name
Telefon
404-380-9263
Name
Adresse
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Name
Mitarbeiter
528
Name
Twitter
@MadrigalPharma
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
MDGL's Discussions on Twitter

Vergleichen Sie MDGL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MDGL
Madrigal Pharmaceuticals Inc
428.67 9.40B 0 -518.67M -438.32M -25.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.27 106.97B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
661.27 68.62B 14.25B 4.58B 3.56B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
444.43 63.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
802.94 50.61B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
188.86 35.29B 398.11M -1.03B -868.57M -5.7032

Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-15 Eingeleitet Truist Buy
2025-09-04 Fortgesetzt H.C. Wainwright Buy
2025-02-28 Hochstufung B. Riley Securities Neutral → Buy
2025-02-27 Bestätigt H.C. Wainwright Buy
2024-06-28 Eingeleitet Cantor Fitzgerald Neutral
2024-06-11 Eingeleitet Wolfe Research Outperform
2024-04-22 Eingeleitet BofA Securities Underperform
2024-03-15 Hochstufung B. Riley Securities Sell → Neutral
2024-03-06 Eingeleitet Citigroup Buy
2024-02-26 Herabstufung B. Riley Securities Neutral → Sell
2022-12-20 Bestätigt Oppenheimer Outperform
2022-12-19 Bestätigt H.C. Wainwright Buy
2022-12-19 Bestätigt Piper Sandler Overweight
2022-12-19 Hochstufung Raymond James Underperform → Mkt Perform
2022-07-08 Herabstufung B. Riley Securities Buy → Neutral
2021-10-07 Eingeleitet Jefferies Buy
2021-08-06 Hochstufung BMO Capital Markets Market Perform → Outperform
2021-05-20 Fortgesetzt Goldman Buy
2020-11-24 Fortgesetzt Evercore ISI Outperform
2020-11-06 Bestätigt H.C. Wainwright Buy
2020-07-31 Eingeleitet Piper Sandler Overweight
2020-06-05 Eingeleitet BMO Capital Markets Market Perform
2020-05-05 Eingeleitet Chardan Capital Markets Buy
2020-01-30 Eingeleitet Canaccord Genuity Buy
2020-01-09 Hochstufung UBS Neutral → Buy
2019-11-07 Bestätigt H.C. Wainwright Buy
2019-06-25 Eingeleitet Stifel Hold
2019-06-10 Hochstufung B. Riley FBR Neutral → Buy
2019-02-28 Bestätigt H.C. Wainwright Buy
2019-02-22 Eingeleitet SVB Leerink Outperform
2019-01-23 Eingeleitet UBS Neutral
2018-12-14 Eingeleitet Wolfe Research Outperform
2018-12-12 Eingeleitet B. Riley FBR Neutral
2018-11-19 Herabstufung Raymond James Mkt Perform → Underperform
2018-11-16 Hochstufung Evercore ISI In-line → Outperform
2018-09-04 Eingeleitet Citigroup Buy
2018-08-06 Herabstufung Goldman Buy → Neutral
2018-06-28 Eingeleitet Raymond James Mkt Perform
Alle ansehen

Madrigal Pharmaceuticals Inc Aktie (MDGL) Neueste Nachrichten

pulisher
10:51 AM

How Madrigal Pharmaceuticals Inc. stock reacts to global recession fearsStock Surge & Real-Time Market Sentiment Alerts - newser.com

10:51 AM
pulisher
07:37 AM

Emerald Advisers LLC Acquires 5,199 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

07:37 AM
pulisher
06:00 AM

Madrigal Pharmaceuticals Grants Equity Awards to New Employees Under 2025 Inducement Plan - MyChesCo

06:00 AM
pulisher
04:44 AM

Is it too late to sell Madrigal Pharmaceuticals Inc.Forecast Cut & Fast Entry High Yield Tips - newser.com

04:44 AM
pulisher
04:13 AM

Madrigal Pharmaceuticals, Inc. $MDGL Shares Sold by D.A. Davidson & CO. - MarketBeat

04:13 AM
pulisher
04:06 AM

How strong is Madrigal Pharmaceuticals Inc. (YDO1) stock earnings growthWeekly Investment Report & Verified Momentum Watchlists - newser.com

04:06 AM
pulisher
03:50 AM

Can Madrigal Pharmaceuticals Inc. stock hit record highs againIndex Update & Free Community Supported Trade Ideas - newser.com

03:50 AM
pulisher
01:49 AM

How forex fluctuations impact Madrigal Pharmaceuticals Inc. (YDO1) stockTrade Ideas & AI Enhanced Trading Signals - newser.com

01:49 AM
pulisher
01:23 AM

Using RSI to spot recovery in Madrigal Pharmaceuticals Inc.Long Setup & Accurate Technical Buy Alerts - newser.com

01:23 AM
pulisher
01:21 AM

Statistical indicators supporting Madrigal Pharmaceuticals Inc.’s strengthQuarterly Profit Summary & Low Drawdown Trading Techniques - newser.com

01:21 AM
pulisher
Oct 29, 2025

Madrigal Pharmaceuticals Inc. stock trendline breakdownMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

How to escape a deep drawdown in Madrigal Pharmaceuticals Inc.Weekly Gains Report & Community Verified Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is Madrigal Pharmaceuticals Inc. trending in predictive chart modelsEarnings Trend Report & Technical Buy Zone Confirmation - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Madrigal Pharmaceuticals Experiences Evaluation Revision Amid Strong Market Performance - Markets Mojo

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal (MDGL) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal to Present New Data from the Company’s MASH Program at AASLD’s The Liver Meeting 2025 - The Manila Times

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Rallies & Real-Time Market Trend Scan - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Madrigal (NASDAQ: MDGL) to present cirrhosis and real-world Rezdiffra data at AASLD 2025 - Stock Titan

Oct 28, 2025
pulisher
Oct 28, 2025

Will Madrigal Pharmaceuticals Inc. (YDO1) stock keep raising dividendsBond Market & Capital Efficiency Focused Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Chart based exit strategy for Madrigal Pharmaceuticals Inc.Quarterly Investment Review & Precise Buy Zone Identification - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How to integrate Madrigal Pharmaceuticals Inc. into portfolio analysis toolsMarket Risk Summary & Reliable Intraday Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Will Madrigal Pharmaceuticals Inc. (YDO1) stock profit from AI boom2025 Earnings Impact & Daily Chart Pattern Signals - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Madrigal Pharmaceuticals set to unveil Q3 2025 financial results on November 4 - Traders Union

Oct 27, 2025
pulisher
Oct 26, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 26, 2025
pulisher
Oct 26, 2025

Is Madrigal Pharmaceuticals Inc a good long term investmentProtective Put Strategies & Unlock Free Weekly Portfolio Checkups - earlytimes.in

Oct 26, 2025

Finanzdaten der Madrigal Pharmaceuticals Inc-Aktie (MDGL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.05
price up icon 1.07%
$93.54
price up icon 3.75%
$28.62
price down icon 1.17%
$105.61
price up icon 2.19%
biotechnology ONC
$309.38
price down icon 1.72%
$189.06
price up icon 13.08%
Kapitalisierung:     |  Volumen (24h):